TWD 53.0
(-5.36%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 5.43 Million TWD | -14.98% |
2022 | 6.38 Million TWD | 144.28% |
2021 | 2.61 Million TWD | -3.0% |
2020 | 2.69 Million TWD | 151.02% |
2019 | 1.07 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 7.83 Million TWD | 47.25% |
2024 Q1 | 5.31 Million TWD | -2.08% |
2023 Q1 | 6.4 Million TWD | 0.0% |
2023 FY | 5.43 Million TWD | -14.98% |
2023 Q4 | 5.43 Million TWD | -30.51% |
2023 Q3 | 7.81 Million TWD | 36.21% |
2023 Q2 | 5.73 Million TWD | -10.36% |
2022 Q4 | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 98.652% |
Level Biotechnology Inc. | 13.5 Million TWD | 59.776% |
TaiMed Biologics Inc. | 750.85 Million TWD | 99.277% |
GlycoNex Incorporation | 900 Thousand TWD | -503.444% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 97.887% |
OBI Pharma, Inc. | 501.05 Million TWD | 98.916% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 98.304% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 98.085% |
Visgeneer Inc. | 158.6 Million TWD | 96.576% |
Neith Corporation | 3.54 Million TWD | -53.375% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 56.931% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.725% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -363.792% |
Enimmune corporation | 45.73 Million TWD | 88.125% |
TaiRx, Inc. | 12.28 Million TWD | 55.795% |
CHO Pharma, Inc. | - TWD | -Infinity% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 90.669% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 98.613% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | 7.918% |
Feng Chi Biotech Corp. | 10.79 Million TWD | 49.704% |
Lukas Biomedical Inc. | 82.55 Million TWD | 93.421% |
RBC Bioscience Corporation | 487.36 Million TWD | 98.886% |
NaviFUS Corp. | 32.69 Million TWD | 83.388% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -51.197% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -909.48% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 62.219% |
Sagittarius Life Science Corp | 13.32 Million TWD | 59.236% |
Bio Preventive Medicine Corp. | 113.44 Million TWD | 95.213% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -524.253% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 58.517% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 79.975% |
Lin BioScience, Inc. | 42.87 Million TWD | 87.332% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -292.697% |
AP Biosciences Inc | 82.07 Million TWD | 93.383% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 96.88% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.203% |
EirGenix Inc. | 465.16 Million TWD | 98.832% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 96.238% |
Mycenax Biotech Inc. | 726.27 Million TWD | 99.252% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -156.906% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -24.736% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 94.395% |
VBI | - TWD | -Infinity% |
BiOptic Inc. | 93.19 Million TWD | 94.173% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 98.698% |
Sinew Pharma Inc. | 6.46 Million TWD | 15.981% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 97.231% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.813% |
3D Global Biotech Inc. | 10.37 Million TWD | 47.673% |
Intech Biopharm Corporation | 1.43 Billion TWD | 99.622% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 98.635% |
TWi Biotechnology, Inc. | 7.97 Million TWD | 31.866% |
TCI GENE Inc. | 6.79 Million TWD | 20.074% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 34.708% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | 43.433% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 97.978% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 49.157% |
PharmaEngine, Inc. | 14.8 Million TWD | 63.326% |
Savior Lifetec Corporation | 270.37 Million TWD | 97.991% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 92.728% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | 84.045% |
Acepodia, Inc. | 273.81 Million TWD | 98.017% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 73.453% |